MICROPLATE:\nwells coated with antihuman IgM monoclonal antibodies.\nCONJUGATE:\nmonoclonal antibodies labelled with peroxidase, in phosphate buffer with phenol 0.05% and bronidox 0.02%. \nPOSITIVE CONTROL:\nDiluted human serum containing anti-Mumps IgM antibodies, in Phosphate buffer 0.01 mol/L with BSA 1% and sodium azide. 0.09%.\nCUT-OFF CONTROL:\nDiluted human serum containing anti-Mumps IgM antibodies, in Phosphate buffer 0.01 mol/L with BSA 1% and sodium azide 0.09%. \nIgM NEGATIVE CONTROL:\nDiluted human serum in Phosphate buffer 0.01 mol/L with BSA 1% and sodium azide 0.09%.\nSUBSTRATE:\nTetramethylbenzidine 0.26 mg/mL and hydrogen peroxide 0.01% stabilised in citrate buffer 0.05 mol/L.\nDILUENT 50X:\nProteic solution concentrated 50 times, with added phenol 0.05% and Bronidox 0.02%. \nWASH BUFFER 10X:\nPhosphate buffered saline, concentrated 10 times; contains Brij 0.5%. \nSTOP SOLUTION:\nH2SO4 0.3 mol/L. \nANTIGEN:\nPurified Mumps virus, inactivated by treatment with beta-propiolactone, in Phosphate
共有 1 個藥物證書使用此成份
- 申請商
- 美艾利爾健康股份有限公司
- 適應症
- 含量
- 發證日期
- 2006-03-24